Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting cancer pathways. Its structure supports binding to ATP sites in kinases, making it valuable in developing drugs for oncology. Also explored in the design of serotonin and dopamine modulators for neurological disorders. Shows potential in medicinal chemistry for optimizing blood-brain barrier penetration due to its amine-containing side chain. Not used in consumer products or industrial applications; limited to laboratory and drug development settings.